Activity observed in a phase I dose escalation trial of the hypoxia-activated, NO prodrug, RRx001 Reid, T. R., Infante, J. R., Burris, H. A., Scribner, C., Knox, S., Oronsky, B., Stephens, J. L., Scicinski, J. AMER SOC CLINICAL ONCOLOGY. 2013

View details for DOI 10.1200/jco.2013.31.4_suppl.241

View details for Web of Science ID 000333679000238